Raymond James & Associates Surmodics Inc Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$43.21 - $57.6 $338,118 - $450,720	-7,825 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$52.8 - $60.32 $206,289 - $235,670	-3,907 Reduced 33.3%	7,825 $435,000
Q2 2021 Aug 11, 2021	BUY	$51.29 - $59.15 $13,643 - $15,733	266 Added 2.32%	11,732 $636,000
Q1 2021 May 14, 2021	BUY	$42.18 - $56.07 $483,635 - $642,898	11,466 New	11,466 $643,000

124

13.2M

25.5K

3.4K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $543M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.